| Table 4. Patient profiles for sub analysis of groups with (S+) and without (S-) cancer surgery. | ||
| S+ group (n=33) |
S- group (n=19) |
|
|---|---|---|
| Age (years) | 38.3±2.9 | 38.8±5.7 |
| BMIa (kg/m2) | 20.4±3.7 | 20.4±2.1 |
| Baseline FSHa (mIU/ml) | 7.94±2.15 | 8.75±3.08 |
| Baseline LHa (mIU/ml) | 3.70±1.71 | 4.88±3.24 |
| Baseline E2a (pg/ml) | 63.8±46.4 | 42.8±23.4b |
| Baseline Ta | 21.2±8.37 | 22.2±8.35 |
| Baseline PRLa | 16.9±12.2 | 19.2±9.2 |
| HOMA-IRa | 1.11±0.51 | 1.52±0.86 |
a BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; T, testosterone; PRL, prolactin; HOMA-IR, homeostasis model assessment - insulin resistance.
b p<0.05 vs. control, unpaired t test.